InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Zelnick Kaufman Beth. Director active across 1 company, notably CorMedix Inc.. Aggregated, 11 disclosures have been published. History available since 12 December 2023. The latest transaction was disclosed on 29 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
Zelnick Kaufman Beth is a declarant linked to CorMedix Inc. on the XNAS market, where the listed role is Chief Legal Officer. She has 10 filings in total, and within the recent sample held, buy and sell amounts are 0 euro each, with filings ranging from 2023-12-14 to 2026-02-06, and the most frequent transaction nature being Attribution.